{"filings":[{"id":565076,"accession_number":"0001213900-26-059864","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2026-05-21T13:13:15+00:00","items":["1.01","9.01"],"status":"ready","headline":"Greenland Mines enters agreement to acquire Neo North Star for $35M in cash and stock","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Total consideration of $35M: $20M cash and $15M in newly issued GRML shares valued at 20-day VWAP.","Neo North Star holds mineral rights in Greenland; closing subject to Greenland government approval under Mineral Activities Act.","AnorTech Inc. receives 5% of Purchase Price ($1M cash + $750k stock) per License Purchase Agreement.","Shenandoah Partners holds warrant for up to 106,122 Neo shares; must exercise before closing or warrant terminates."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":528998,"accession_number":"0001213900-26-059108","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K/A","filed_at":"2026-05-19T21:05:43+00:00","items":["9.01"],"status":"ready","headline":"Greenland Mines amends 8-K: acquired assets not a business, no financials needed","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Company determined Greenland Mines, Inc. assets do not constitute a business under Rule 3-05 of Regulation S-X.","No separate financial statements or pro forma financial information required under Item 9.01 of Form 8-K.","This amendment clarifies the original Form 8-K filed on March 10, 2026 regarding the acquisition."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":84121,"accession_number":"0001213900-26-056356","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2026-05-14T15:22:41+00:00","items":["7.01","9.01"],"status":"ready","headline":"Greenland Mines presents Skaergaard project resource details at investor conference","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["President Bo Møller Stensgaard presents Skaergaard PGM-Au-V-Ga-Fe-Ti project in Toronto on May 14, 2026.","Skaergaard hosts 159 Mt Indicated and 205 Mt Inferred gold, palladium, platinum resource (NI 43-101).","Gross in-situ metal value estimated at ~$68 billion at February 2026 prices (illustrative only).","Company engaged GTK Mintec for integrated mineralogical, metallurgical and pilot-scale test work.","Additional by-product potential for vanadium, gallium, iron and titanium under evaluation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":96686,"accession_number":"0001213900-26-046512","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2026-04-22T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Greenland Mines appoints Jason D. Sawyer to Board of Directors, effective April 17, 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jason D. Sawyer appointed to fill a vacancy on the Board, effective immediately on April 17, 2026.","He will serve until the next annual meeting; not appointed to any board committees.","Mr. Sawyer is a 33-year alternative investment veteran and General Manager of Access Alternative Group S.A.","He currently serves as CEO/Director of GridAI Technologies (GRDX) and on boards of QNTM, LIXT, PDC, and FTRC.","No family relationships or material transactions with the Company; no agreement regarding appointment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110803,"accession_number":"0001213900-26-032870","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2026-03-23T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Greenland Mines gets 180-day Nasdaq bid price compliance extension to Sep 14, 2026","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq granted additional 180-day extension through September 14, 2026 to regain $1 bid compliance.","Must close at or above $1.00 for 10 consecutive business days during the extension period.","Company meets all other Nasdaq listing requirements; failure to comply may lead to delisting.","Initial non-compliance notice received September 19, 2025; previous extension ended March 18, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110802,"accession_number":"0001213900-26-028158","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2026-03-16T23:59:59+00:00","items":["5.03","7.01","8.01","9.01"],"status":"ready","headline":"Klotho Neurosciences renames to Greenland Mines Ltd, ticker becomes GRML","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Name changed from Klotho Neurosciences, Inc. to Greenland Mines Ltd effective March 11, 2026 via Delaware merger.","Nasdaq ticker changed to GRML effective March 12, 2026; no action required by shareholders.","Company to hold investor webcast on March 12, 2026 at 4:15PM ET to discuss strategic rationale of recent acquisition.","CUSIP number for common stock remains unchanged."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110801,"accession_number":"0001213900-26-026922","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2026-03-12T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Greenland Mines completes acquisition, launches as mineral resource company with $68B in-situ resource value","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Acquisition of Greenland Mines closed March 4, 2026; consideration is convertible preferred equity subject to shareholder approval.","Company name changed to Greenland Mines Ltd, ticker to GRML, effective March 12, 2026, with two divisions: Natural Resources and Cell and Gene Therapy.","Skaergaard Project in Southeast Greenland holds 23.5 Moz AuEq indicated+inferred; in-situ value ~$68B at Feb 2026 metal prices.","Greenland Mines owns 80% of Skaergaard; new drilling program aims to double resource to ~50 Moz contained ounces of Au, Pd, and Pt.","Project benefits from Tier 1 jurisdiction, no third-party royalties, and proximity to Europe and North America."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110808,"accession_number":"0001213900-26-025750","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2026-03-10T23:59:59+00:00","items":["1.01","2.01","3.02","5.03","9.01"],"status":"ready","headline":"Klotho Neurosciences acquires Greenland Mines; issues 47k Series C Preferred shares for Skaergaard Project","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Merger consideration: 47,000 Series C Preferred shares; each convertible into 42,554 common shares after stockholder approval.","Greenland Mines holds 80% of Major Precious Greenland A/S, owner of Skaergaard Project with 25.4 Moz PdEq and 23.5 Moz AuEq resources.","Series C Preferred is non-voting and non-convertible until stockholder approval is obtained at a special or annual meeting.","No change in control or in executive officers/directors of Klotho as a result of the merger."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110807,"accession_number":"0001213900-26-023666","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2026-03-04T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Klotho Neurosciences acquires Greenland Mines; 93% dilution to existing holders for Skaergaard project","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquisition of Greenland Mines Corp. for convertible preferred stock; on conversion GMC holders get ~93% of fully diluted shares.","Skaergaard Project hosts 25.4 Moz PdEq and 23.5 Moz AuEq; gross in-situ resource value ~$68B (Feb 2026 prices).","Transaction expected to be accounted for as a reverse merger; company to rebrand as Greenland Mines, new ticker in late March.","Klotho will retain cell & gene therapy division (ALS program KLTO-202); Greenland Mines CEO Bo Møller Stensgaard joins management.","Undeveloped palladium-gold deposit in Greenland; 80% interest owned, option for remaining 20%."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.95,"calibrated_materiality_score":0.95,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110806,"accession_number":"0001213900-26-022411","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2026-03-02T23:59:59+00:00","items":["3.02"],"status":"ready","headline":"Klotho Neurosciences closes $7.75M private placement of 34.5M shares and warrants","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds of ~$7.75M from 34,551,939 shares and warrants for same number of shares.","Warrants exercisable for common stock; terms described in Feb. 24 8-K.","Sale to accredited investors under Section 4(a)(2) and Regulation D exemption.","Closed on March 2, 2026; no general solicitation or advertising."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110805,"accession_number":"0001213900-26-019436","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2026-02-24T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Klotho Neurosciences raises ~$7.75M through sale of 34.55M shares and warrants at $0.2243/share","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issued 34,551,939 shares at $0.2243 per share to 10 investors, raising approximately $7.75M.","Investors also received five-year warrants for same number of shares at $0.2243 exercise price.","Warrants cannot be exercised until stockholder approval is obtained.","Closing expected on or before March 15, 2026; shares and warrants sold as units in a private placement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110804,"accession_number":"0001213900-26-017490","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2026-02-17T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Klotho Neurosciences shareholders approve reverse stock split and equity plan increase","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholders approved reverse stock split at ratio between 1:2 and 1:50, as determined by Board.","Approved amendment to 2024 Equity Incentive Plan to increase authorized shares to 10,000,000.","On record date Jan 15, 2026, 73,536,722 common shares outstanding; 30,457,004 votes cast (quorum).","Reverse split proposal: 27.6M for, 2.6M against; Equity Plan amendment: 11.1M for, 3.6M against, 15.7M broker non-votes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":127432,"accession_number":"0001213900-25-119257","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2025-12-08T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Klotho Neurosciences raises ~$15M via sale of Series C convertible preferred stock to Sigma9 Capital","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sold 3,400 shares of Series C Preferred at $4,400/share to Sigma9 Capital Ltd for total proceeds of ~$15.0M.","Each share convertible into 10,000 common shares, subject to 9.99% beneficial ownership cap and Nasdaq stockholder approval if needed.","Conversion terms potentially add up to 34M shares of common stock upon conversion (dilutive).","Closing expected by December 31, 2025; no underwriters, no commissions, relying on Section 4(2) exemption."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":144218,"accession_number":"0001213900-25-091661","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2025-09-25T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Klotho Neurosciences extends subscription agreement with Meteora funds, caps shares at 6.755M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Amendment to June 13, 2024 Subscription Agreement with Meteora funds executed September 19, 2025.","Term of agreement extended to September 19, 2025.","Maximum number of shares issuable under the agreement fixed at 6,755,000.","Parties include Meteora Special Opportunity Fund I, LP, Meteora Capital Partners, LP, and others."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":144217,"accession_number":"0001213900-25-091652","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2025-09-25T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Klotho Neurosciences receives Nasdaq delisting notice for bid price non-compliance","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq notice on Sept 19, 2025 for failing minimum bid price of $1 for 30 consecutive business days.","Has 180 days, until March 18, 2026, to regain compliance.","To regain compliance, closing bid price must be at least $1 for ten consecutive business days.","Failure to comply will result in delisting from Nasdaq."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":144216,"accession_number":"0001213900-25-075016","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2025-08-12T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Klotho Neurosciences signs $250K manufacturing deal with AAVnerGene for KLTO-202 gene therapy","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Initial fees of $250,000; additional fees tied to clinical trial stages plus 2% royalty on product revenue.","Agreement covers manufacturing and development of KLTO-202 using AAVnerGene's AAVone platform technology.","AAVnerGene's ATHENA tissue-targeting system aims to avoid liver homing and reduce inflammatory side effects.","CEO states partnership expected to lower cost, increase purity, and accelerate time to clinic."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":144212,"accession_number":"0001213900-25-066745","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K/A","filed_at":"2025-07-23T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Klotho Neurosciences amends 8-K to correct resignation date of director Edward Cong Wang","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Director Edward Cong Wang resigned from the Board effective August 26, 2024 (corrected from August 25).","Mr. Wang also waived his contractual right to appoint a successor director.","Mr. Wang had served as Director and CFO prior to the business combination and remained as sponsor nominee.","No replacement has been announced; board size reduced by one."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":144215,"accession_number":"0001213900-25-066676","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2025-07-22T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Klotho Neurosciences enters exclusive global gene therapy license with AAVnerGene","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Exclusive global rights to AAVnerGene's AAVone platform for three gene therapy programs: KLTO-101, KLTO-202, KLTO-303.","Initial license fees: $250,000 (first product) to $500,000 (third product); plus 2% royalty on revenue.","Targets Alzheimer's, Parkinson's, ALS, motor neuron diseases, and aging-related pathologies.","CEO cites faster, cheaper manufacturing with higher purity and lower toxicity via AAVone and ATHENA platforms.","Partnership aims to accelerate clinical development and reduce high drug price/dose-related toxicity."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":144214,"accession_number":"0001213900-25-065744","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2025-07-18T23:59:59+00:00","items":["3.01","7.01","9.01"],"status":"ready","headline":"Klotho regains Nasdaq bid price and equity compliance; phase-down to Capital Market approved","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Regained compliance with Nasdaq minimum $1.00 bid price and $2.5M stockholders' equity requirements.","Nasdaq approved phase-down of listing from Global Market to Capital Market; shares trade as KLTO and KLTOW.","One-year monitoring period for equity compliance; non-compliance could lead to delisting without cure period."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":144213,"accession_number":"0001213900-25-062859","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2025-07-10T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"FDA grants Orphan Drug Designation for Klotho's KLTO-202 to treat ALS","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["FDA granted Orphan Drug Designation for KLTO-202 (s-KL-AAV.myo) for ALS.","Designation provides tax credits for clinical trials, GDUFA fee waiver, and 7-year U.S. market exclusivity.","Company completed proof-of-concept in two animal ALS models; initiating manufacturing and FDA/EMA meetings.","KLTO-202 is a gene therapy using a muscle-specific desmin promoter to deliver secreted-Klotho protein."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":162566,"accession_number":"0001213900-25-059753","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2025-06-30T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Klotho Neurosciences begins manufacturing of ALS gene therapy KLTO-202, targeting Phase I/II start by Q3 2026","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["KLTO-202 gene therapy manufacturing underway; process development & manufacturing expected to take approx. 8 months.","Company targets FDA meetings, animal safety studies, IND filing, and Phase I/II trial start by Q3 2026.","Therapy uses s-KL RNA splice variant of alpha-Klotho gene licensed from Autonomous University of Barcelona.","Animal studies in ALS, Alzheimer's, and aging models showed favorable therapeutic outcomes.","Company will use CROs to manage manufacturing and clinical trials, avoiding large staff increases."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":162565,"accession_number":"0001213900-25-054508","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2025-06-16T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Klotho Neurosciences raises over $11M, retires all debt, exceeds Nasdaq equity requirement","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Raised $11M+ from warrant exercises over June 8-13, 2025; Chardan acted as exclusive financial advisor.","Used $3.1M of proceeds to extinguish all outstanding debt, resulting in a debt-free balance sheet.","Believes stockholders' equity now exceeds Nasdaq's $2.5M minimum requirement for continued listing.","Intends to notify Nasdaq to request a compliance determination; no assurance of outcome provided."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":162564,"accession_number":"0001213900-25-054373","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2025-06-13T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Klotho Neurosciences terminates Skybell acquisition; sells $500k Series B preferred stock","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Mutually terminated March 26, 2025 Share Exchange Agreement to acquire SBSH from Skybell Technologies.","Termination and Release Agreement signed June 13, 2025; no liability incurred by either party.","Issued $500,000 of Series B Preferred stock convertible into common after registration effective.","Sale exempt from registration under Section 4(2) of Securities Act; no underwriters or commissions paid."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":162563,"accession_number":"0001213900-25-053245","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2025-06-11T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Klotho Neurosciences reprices warrants to $1.35, corrects June 5 stock sale to 6.25M shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Warrant exercise price reduced to $1.35 for period June 10-20, 2025; otherwise reverts to $3.49.","Corrects earlier report: 6,250,000 shares sold on June 5 for total $500,000 (approx $0.08/share).","Stock sale exempt under Section 4(2) of Securities Act; no underwriters or commissions paid."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":162562,"accession_number":"0001213900-25-052898","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2025-06-10T23:59:59+00:00","items":["1.01","3.02","7.01","9.01"],"status":"ready","headline":"Klotho Neurosciences announces s-KL longevity study; also closes $500K stock sale and reprices warrants","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Pre-clinical study shows s-KL protein increased lifespan 20% in mice; company holds exclusive license for s-KL patents from UAB/ICREA.","Sold 4M shares for $500K ($0.125/share) in unregistered sale on June 5, 2025.","Repriced 4,515,762 public warrants to $1.35/share on June 10, 2025; other terms unchanged.","CEO focuses s-KL development on neurodegenerative diseases: ALS, Alzheimer's, Parkinson's.","Prof. Makoto Kuro-O, original Klotho discoverer, serves as scientific advisor."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":162561,"accession_number":"0001213900-25-050081","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2025-06-02T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Stockholders approve reverse stock split of Klotho Neurosciences at ratio of 1:2 to 1:50","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Special meeting held May 28, 2025; quorum present with 20,321,223 common shares represented.","Proposal approved with 18,977,235 votes for, 1,343,426 against, and 562 abstentions.","Board authorized to determine final exchange ratio between 1-for-2 and 1-for-50.","Adjournment proposal moot due to sufficient votes to approve the reverse split."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":162560,"accession_number":"0001213900-25-033837","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2025-04-21T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Klotho Neurosciences receives Nasdaq bid price non-compliance notice; response due April 22","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq notice on April 15, 2025, for continued failure to meet minimum $1 bid price (Rule 5450(a)(1)).","Company must present its views to Nasdaq Hearings Panel in writing by April 22, 2025, on this additional deficiency.","Panel had granted extension to August 13, 2025, subject to milestones; potential delisting if compliance not shown.","Company still addressing prior MVPHS and MVLS non-compliance; hearing held March 27, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":162559,"accession_number":"0001213900-25-029068","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2025-04-04T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Klotho Neurosciences receives Nasdaq extension to Aug 13, 2025 for listing compliance","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq Hearing Panel granted extension until August 13, 2025 to regain compliance with MVPHS and MVLS rules.","Extension is contingent on achieving scheduled milestones and notifying Nasdaq of such achievement.","Company previously received delisting notice on Feb 14, 2025 for non-compliance; hearing held March 28, 2025.","If milestones not met within prescribed time, Panel may revoke extension and proceed with delisting.","Non-compliance stems from minimum Market Value of Publicly Held Shares and Listed Securities requirements."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":162558,"accession_number":"0001213900-25-027228","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2025-04-01T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Klotho to acquire SkyBell doorbell unit for 90% of its fully diluted stock","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Klotho to acquire SB Security Holdings (SkyBell video doorbell) for 90% of its fully diluted common stock.","Existing Klotho shareholders would hold ~10% of combined entity after issuance of purchase consideration.","Closing conditioned on stockholder approval, Nasdaq approval, S-4 effectiveness, and secured creditor consent.","Agreement signed March 26, 2025; closing must occur by August 13, 2025.","SkyBell is an internet-connected video doorbell service; Klotho is a neuroscience biotech company."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.95,"calibrated_materiality_score":0.95,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":180557,"accession_number":"0001213900-25-016204","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2025-02-24T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Klotho Neurosciences receives Nasdaq delisting notice; appeals hearing requested","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received delisting notice on Feb 14, 2025 for failing MVPHS and MVLS requirements under Nasdaq Listing Rules 5450(b)(2)(C) and (b)(2)(A).","Company had until Feb 12, 2025 to regain compliance but did not meet the deadline.","On Feb 21, 2025, company requested a hearing to appeal, which stays suspension and Form 25-NSE filing pending panel decision.","Hearing request and applicable fee were submitted to Nasdaq per Listing Rule 5800 Series."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":180556,"accession_number":"0001213900-25-006105","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2025-01-24T23:59:59+00:00","items":["1.01","2.03","3.02","9.01"],"status":"ready","headline":"Klotho Neurosciences raises $2M via convertible notes and warrants with institutional investor","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Aggregate purchase price of $2M for convertible notes (principal $2,173,914) and warrants (4M shares).","First closing: $1M for $1,086,957 note (7% interest, 8% OID) and warrant to buy 2M shares at $0.50.","Notes convertible at $0.25/share; conversion capped at 4.99% (9.99% optional) of outstanding common stock.","Registration statement to be filed within 15 days; second $1M closing conditional on SEC effectiveness.","Stockholder meeting within 90 days to approve issuance exceeding 19.99% of outstanding shares; voting agreement in place."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":197380,"accession_number":"0001213900-24-107459","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2024-12-10T23:59:59+00:00","items":["1.01","2.03","3.02","9.01"],"status":"ready","headline":"Klotho Neurosciences enters $1.2M convertible note with 20% OID, 2M inducement shares","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Principal $1.2M, 20% original-issue discount, unsecured, no interest, matures Dec 4, 2025.","Convertible into common at $0.25/share after stockholder approval; 4.99% ownership cap applies.","Investor Austria Capital LLC received 2,000,000 common shares as inducement to purchase the note.","Note issued under Section 4(a)(2) private placement; no affirmative or restrictive covenants."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":197379,"accession_number":"0001213900-24-102256","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2024-11-25T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Klotho Neurosciences appoints former Merck US President Riad El-Dada to Board of Directors","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Riad El-Dada appointed to fill Board vacancy, term expires at next annual stockholder meeting.","El-Dada is former Merck US President, led teams in 12 therapeutic areas accounting for over $12B in revenue.","He currently serves on boards of MKG Group and Merck Sharp & Dohme Federal Credit Union, and advises life sciences firms.","Compensation will match standard non-employee director packages; no material transactions with the company disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":197378,"accession_number":"0001213900-24-097018","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2024-11-13T23:59:59+00:00","items":["1.02","9.01"],"status":"ready","headline":"Klotho terminates licensing deal for gamma-melanocortin MC1R rights","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Mutual termination of Jan 28, 2023 licensing agreement with Teleost Biopharmaceuticals.","Licensed rights no longer core to Klotho's business and research plans.","No further obligations or liabilities between parties; confidentiality survives.","Agreement covered worldwide rights to develop gamma-melanocortin drugs targeting MC1R receptors."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":197377,"accession_number":"0001213900-24-092913","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2024-10-31T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Klotho Neurosciences dismisses auditor Yusufali after PCAOB disqualification; names BCRG Group","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Terminated Yusufali & Associates as auditor on Oct 26, 2024, due to PCAOB disqualification.","Engaged BCRG Group as new independent registered public accounting firm on Oct 28, 2024.","Yusufali's prior reports included going-concern doubt but no adverse or qualified opinions.","No disagreements with Yusufali on accounting principles or audit scope in past two years."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":197376,"accession_number":"0001213900-24-092389","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2024-10-31T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"CEO Joseph Sinkule signs new 3-year contract with $360K salary, 1M options","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Base salary $360,000/year; eligible for annual bonus program under Board/Comp Committee approval.","Receives 1,000,000 stock options under 2023 Incentive Plan, 3-year term, exercise = Oct 24, 2024 close.","Term Oct 24, 2024 to Oct 24, 2027; post-term employment at-will.","Non-compete: 1 year after termination (except without cause); restricted in neurological cell/gene therapy and oncology biosimilars.","On termination, unvested shares/options vest immediately; if Company terminates (non-cause), one additional year salary paid."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":197375,"accession_number":"0001213900-24-089335","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2024-10-21T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Klotho Neurosciences receives Nasdaq deficiency notice for bid price; compliance deadline April 14, 2025","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Received Nasdaq notice on Oct 15, 2024 for failing to maintain $1 minimum bid price for 30 consecutive business days.","Company has 180 calendar days, until April 14, 2025, to regain compliance.","To cure, closing bid price must be at least $1 for 10 consecutive business days.","If compliance is not regained, the common stock will be subject to delisting from Nasdaq."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":197374,"accession_number":"0001213900-24-084456","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2024-10-02T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Dr. Robert Langer, co-founder of Moderna, joins Klotho Neurosciences Scientific Advisory Board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Dr. Langer appointed to Scientific Advisory Board effective September 24, 2024, per agreement filed.","He will advise on neuroscience and needle-free injector programs; role is non-binding without fiduciary duties.","Klotho focuses on neurodegenerative diseases using patented s-KL protein platform (USA, Europe, Hong Kong, China).","Dr. Langer previously co-authored a paper with CEO Joseph Sinkule."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":213616,"accession_number":"0001213900-24-074551","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2024-08-30T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Edward Cong Wang resigns from ANEW Medical board on Aug 25, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Edward Cong Wang resigned as a member of the Board of Directors on August 25, 2024.","Wang previously served as Director and CFO before the company's business combination.","No replacement director has been announced; board seat remains vacant."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":213615,"accession_number":"0001213900-24-071578","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2024-08-22T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"ANEW Medical appoints CFO LeBlanc ($325k base) and COO Moriarty ($300k base) effective Aug 15","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jeffrey LeBlanc appointed CFO effective Aug 15, 2024; 3-year term, base salary $325k, initial 100k shares + 400k shares vesting over 2 years.","Peter Moriarty appointed COO effective Aug 15, 2024; 3-year term, base salary $300k, initial 100k shares + 400k shares vesting over 2 years.","LeBlanc has 20+ years finance experience, co-founded SPAC Winvest (WINV), earlier roles at Greenlight Capital, GE Capital, McKinsey.","Moriarty co-founded Shire Pharmaceuticals (acquired by Takeda), led Prismic Pharma, and has extensive pharma industry experience."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":213614,"accession_number":"0001213900-24-071576","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2024-08-22T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"ANEW Medical receives Nasdaq delisting notices for MVPHS and MVLS non-compliance","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq notified ANEW Medical on Aug 16, 2024 for failing MVPHS ($15M) and MVLS ($50M) requirements.","Company has 180 days, until Feb 12, 2025, to regain compliance for 10 consecutive business days.","Failure to regain compliance will result in delisting of common stock from Nasdaq.","Common stock trades under symbol WENA; warrants under WENAW."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":213613,"accession_number":"0001213900-24-065203","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2024-08-05T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"ANEW Medical interim CFO Edward Cong Wang resigns, remains director","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Edward Cong Wang resigned as interim CFO effective July 30, 2024.","Wang had served as CFO before the business combination and remained interim CFO post-closing.","Wang will continue serving as a Director of the Company.","No replacement interim or permanent CFO has been announced."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":232819,"accession_number":"0001213900-24-056719","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2024-06-27T23:59:59+00:00","items":["1.01","2.01","5.02","5.05","3.02","9.01","4.01","3.03","5.01","5.03","5.06"],"status":"ready","headline":"Redwoods Acquisition Corp. closes merger with ANEW Medical, renamed ANEW Medical, Inc.","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Business combination closed June 21, 2024; combined company now named ANEW Medical, Inc. (ticker: WENA).","Post-combination shares outstanding: 15,130,393; top holders: Redwoods Capital LLC (20.6%), Chardan Capital Markets (9.9%).","Six-month lock-up agreements with CEO Joseph Sinkule and other holders restrict share sales until Dec. 21, 2024 or change-of-control event.","CEO Sinkule assigned ~2.65M shares to Chardan, White Lion, Centaurus, and others for investment banking/financing; company plans to reimburse with new shares.","Pro forma financial statements to be filed via amendment; full audited financials of legacy companies provided in exhibits."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":232826,"accession_number":"0001213900-24-054153","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2024-06-20T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Redwoods SPAC files restated ANEW Medical audited financials; prior auditor barred by SEC","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["ANEW Medical net loss $707K in FY2023 vs $599K in FY2022; accumulated deficit $3.9M.","New auditor Yusufali & Associates re-audited 2022 and audited 2023 after B.F. Borgers barred by SEC.","Cash at Dec 2023 was $2,808; going concern doubt flagged in audit opinion.","Five German anti-cancer drugs acquired in Sep 2022 for $1.39M; no revenue yet.","Business combination with Redwoods expected to close in 2024, subject to approvals."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":232825,"accession_number":"0001213900-24-052619","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2024-06-14T23:59:59+00:00","items":["1.01","3.02","8.01","9.01"],"status":"ready","headline":"RWOD enters Forward Purchase with Meteora for up to 1M shares; notes 1.59M redemption requests","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Forward Purchase Agreement with Meteora entities for up to 1,000,000 shares at $10.00 to support ANEW Medical merger.","Seller may purchase shares via PIPE subscription; shares unregistered, issued under Section 4(a)(2).","As of June 13, 2024, RWOD received redemption requests for 1,589,776 shares at ~$10.80 each.","Redemptions could reduce trust account funds available for the combined company.","Business combination with ANEW Medical remains pending, subject to stockholder approval and closing conditions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":232820,"accession_number":"0001213900-24-052949","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K/A","filed_at":"2024-06-14T23:59:59+00:00","items":["8.01","1.01","3.02","9.01"],"status":"ready","headline":"RWOD corrects redemption price to $10.78; signs Meteora backstop for ANEW merger","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Redemption price corrected to $10.78 per share (trust balance $18.99M; net of $770k tax withdrawal).","Received redemption requests for 1,589,776 shares as of June 13, 2024.","Forward Purchase Agreement with Meteora for up to 1,000,000 shares to backstop the $60M ANEW merger.","Subscription Agreement also executed for FPA funding PIPE with Meteora entities.","Prior May 2024 disclosure of $11.20 redemption price did not reflect the tax withdrawal."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":232824,"accession_number":"0001213900-24-041421","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2024-05-10T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Redwoods Acquisition secures non-redemption agreement for up to 360K shares amid 1.59M redemptions","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Redemption requests total 1,589,776 shares as of May 8; only 170,418 shares will remain outstanding post-redemption.","Non-redemption agreement with backstop investors to reverse up to 360,000 shares previously submitted for redemption.","Backstop investors receive cash from trust equal to Redemption Price ($11.20) less $5.00 per share for each reversed share.","Agreement supports pending business combination with ANEW MEDICAL, INC.; deal closing still subject to conditions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":232823,"accession_number":"0001213900-24-034182","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2024-04-18T23:59:59+00:00","items":["5.07","7.01"],"status":"ready","headline":"Redwoods Acquisition stockholders approve ANEW Medical merger; 1.74M shares redeemed","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All six proposals passed with strong support; business combination adoption received 4,185,975 for, 3,052 against.","Stockholders elected to redeem 1,739,776 shares of Class A common stock (~33.7% of record-date shares) in connection with the meeting.","Five directors elected to serve on combined company's board effective at closing: Sinkule, Hirschman, Zentman, McGarity, Wang.","Proposals adopted include second amended charter, 2023 stock incentive plan, and Nasdaq-required issuance approval."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":232822,"accession_number":"0001213900-24-032341","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2024-04-12T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Redwoods Acquisition adjourns special meeting to April 12; redemption reversal allowed","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Special meeting reconvened Apr 8, 2024, adjourned without business; next meeting Apr 12, 2024 at 10 a.m. ET.","Stockholders who tendered shares for redemption may withdraw request before vote at Apr 12 meeting.","Meeting relates to proposed business combination with ANEW MEDICAL Inc."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":232821,"accession_number":"0001213900-24-030889","cik":1907223,"company_name":"Greenland Mines Ltd","ticker":"GRML","form_type":"8-K","filed_at":"2024-04-05T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Redwoods Acquisition adjourns special meeting to Apr 8; allows redemption withdrawal","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Special meeting reconvened April 1, 2024, adjourned without business; next session April 8, 2024 at 10:00 a.m. ET.","Stockholders who tendered shares for redemption may withdraw by contacting transfer agent before the April 8 vote.","Company continues soliciting proxies; meeting accessible via live webcast.","Reversal of redemption requests permitted after prior adjournment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":43718661.196666665,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2024-04-05T23:59:59+00:00|232821"}